Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.080024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Cristian Cojocaru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania. Hauptthemen laut MEDLINE: Lung Neoplasms, Drug Development, Antineoplastic Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
ORCID-Profile: Cristian Cojocaru, Marcel Costuleanu, Decebal Vasîncu
Zitieren
APA
Cojocaru, C., Costuleanu, M., Petriș, O. R., Cojocaru, R., Vasîncu, D., & Cojocaru, E. (2026). Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.080024
Vancouver
Cojocaru C, Costuleanu M, Petriș OR, Cojocaru R, Vasîncu D, Cojocaru E. Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.080024
BibTeX
@article{Cojocaru2026,
author = {Cojocaru, Cristian and Costuleanu, Marcel and Petriș, Ovidiu Rusalim and Cojocaru, Ruxandra and Vasîncu, Decebal and Cojocaru, Elena},
title = {Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.080024}
}
EUVIMED